Skip to main content
Figure 2 | Journal of Ovarian Research

Figure 2

From: Augmented inhibition of angiogenesis by combination of HER2 antibody chA21 and trastuzumab in human ovarian carcinoma xenograft

Figure 2

Tumor microvessel density (MVD) and VEGF expression. (A) The VEGF and CD34 (marker for MVD) expression in SKOV-3 xenografts were detected by immunohistochemistry. (B) Tumor MVD and MOD of VEGF expression were calculated and the values were shown as percents of the control treatment. *, P < 0.01 compared with control. **, P < 0.01 compared with chA21 or trastuzumab alone.

Back to article page

Journal of Ovarian Research

ISSN: 1757-2215

Contact us